A safety study of tradipitant for stomach paralysis
Treatments studied
Part of Digestive system clinical trials.
This study is testing the safety of an investigational drug called tradipitant in people with stomach paralysis (gastroparesis) caused by unknown reasons or diabetes. It looks at how well the drug is tolerated over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with gastroparesis (stomach paralysis).
- You have tested positive for delayed gastric emptying (food stays in the stomach too long).
- You have moderate to severe nausea.
- Your body mass index (BMI) is between 18 and 40.
- Your blood sugar is under control if you have diabetes (HbA1C 11% or less).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether placing a small, implanted device that sends gentle electrical pulses to the stomach can improve symptoms of severe gastroparesis—a condition where the stomach empties too slowly. It's for people whose symptoms haven't been controlled with other treatments and are significantly affecting their daily life.
This study follows people with drug-refractory gastroparesis (stomach paralysis symptoms that don’t improve with usual medicines) to better understand how symptoms and nutrition change over time. Your information may help researchers understand patterns that could improve care.
This trial focuses on people with type 2 diabetes who have slow stomach emptying (gastroparesis). It may help learn better ways to manage symptoms like feeling full quickly or nausea.
This trial tests a new treatment called washed microbiota transplantation for diabetic gastroparesis, a condition where the stomach empties slowly due to diabetes. If you have had diabetes for over a year and struggle with bloating or feeling full quickly, this study may explore whether transplanting healthy gut bacteria can help relieve your symptoms.
This trial tests a new way to program an implanted device (Enterra®) to better treat severe nausea and vomiting caused by gastroparesis. If you have frequent nausea and vomiting despite other treatments, this study might help find a better setting for your device.
This study looks at whether abnormal function of the pyloric “stomach outlet” muscle is linked to gastroparesis symptoms (slow stomach emptying). It may help researchers better understand what causes symptoms and guide future treatments.
Hear when a new Diabetic Gastroparesis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.